Journal article
Experimental Neurology, 2020
APA
Pol, S. U., Liang, S., Schweser, F., Dhanraj, R., Schubart, A., Preda, M., … Zivadinov, R. (2020). Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice. Experimental Neurology.
Chicago/Turabian
Pol, Suyog U., Serena Liang, F. Schweser, Ravendra Dhanraj, A. Schubart, Marilena Preda, M. Sveinsson, et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology (2020).
MLA
Pol, Suyog U., et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology, 2020.